Analysis of the GEO database revealed that LOXL1, LOXL2, and LOXL3 expression levels were significantly elevated in osteosarcoma tissue samples compared to normal bone, indicating their involvement in disease progression. Here, LOXL2 is linked to osteosarcoma.